Elderly Care Products Market Size & Share 2026-2035
Market Size - By Product Type (Mobility Products, Bathroom Safety Products, Comfort Care Products, Medical Devices, Incontinence Products, Nutritional Supplements, Daily Living Aids & Others), By Care Type (Home Care & Independent Living Support, Chronic Disease Management, Post-Acute Rehabilitation Care, Palliative & End-of-Life Care, Preventive Health Management), By End Use (Home-Based Care, Hospitals & Clinics, Nursing Homes & Skilled Nursing Facilities, Assisted Living & Continuing Care Retirement Communities (CCRCs), Adult Day Care & Rehabilitation Centers), and By Distribution Channel (Offline, Online). The market forecasts are provided in terms of revenue (USD Billion) and volume (Thousand Units).
Download Free PDF

Elderly Care Products Market Size
The global elderly care products market was valued at USD 48.8 billion in 2025 and is projected to reach USD 83.3 billion by 2035, registering a compound annual growth rate (CAGR) of 5.4% over the forecast period, according to the latest report published by Global Market Insights Inc.
Elderly Care Products Market Key Takeaways
Market Size & Growth
Regional Dominance
Key Market Drivers
Challenges
Opportunity
Key Players
The growth trajectory reflects an irreversible demographic shift: the global population aged 65 and over is expanding faster than any other age cohort, sustaining long-horizon demand across mobility, medical monitoring, nutritional, and incontinence care categories.[1] The more consequential structural dynamic is the parallel reorientation of care delivery away from institutional settings and toward home environments which is reconfiguring both product mix and channel economics across all major geographies.
Key Drivers
Increasing Aging Population
The global population aged 65 and over is projected to reach 1.6 billion by 2050, up from approximately 771 million in 2022, according to the World Health Organization. This demographic expansion is not uniform: high-income economies in North America, Western Europe, and East Asia are aging fastest in absolute terms, while middle-income markets in South and Southeast Asia are recording accelerating growth in their elderly cohorts. From a market standpoint, every percentage-point increase in the population share aged 65 and over translates to a measurable uplift in per-capita demand for mobility aids, incontinence products, and chronic disease management devices. The underlying driver is the concentration of multiple comorbidities in the 75-and-older cohort, which generates disproportionate per-individual spending relative to younger elderly segments.
Growing Need for In-Home and Institutional Care
The shift from hospital-centred to distributed care settings encompassing home health, assisted living, and skilled nursing is creating differentiated demand pools across multiple elderly care product categories. In the United States, home health expenditures reached USD 125.6 billion in 2023, reflecting a structural pivot in how care is financed and delivered at the payer level.[2] Institutional operators, including nursing homes and continuing care retirement communities (CCRCs), are simultaneously expanding their product procurement budgets as occupancy recovers to pre-pandemic levels. The second-order effect is a diversification of product specifications: home-based care demands lightweight, user-operable formats, while institutional procurement favours clinical-grade durability and bulk-supply economics creating two increasingly distinct product tiers within most categories.
Rising Chronic Diseases in Senior Citizens
Approximately 85% of adults aged 65 and over in the United States manage at least one chronic condition, and more than 60% live with two or more, according to the Centers for Disease Control and Prevention.[3] cardiovascular disease, type 2 diabetes, chronic obstructive pulmonary disease (COPD), and musculoskeletal disorders are the dominant demand drivers for medical devices and nutritional supplements. The data indicates that chronic disease prevalence among the elderly is increasing not only in high-income countries but also across middle-income markets, where improved life expectancy is outpacing healthcare infrastructure development. This gap between longevity and institutional care capacity is a structural tailwind for home-compatible chronic disease management products across all regions.
Drivers Impact Analysis
Driver
(~) % Impact on CAGR Forecast
Geographic Relevance
Impact Timeline
Increasing aging population
+2.0%
Global - concentrated in NA, Europe, APAC
Long term (≥ 4 years)
Growing need for in-home & institutional care
+1.8%
North America, Europe
Medium term (2–4 years)
Rising chronic diseases in senior citizens
+1.6%
Global - high prevalence in NA, Europe
Long term (≥ 4 years)
Key Challenges
High Cost of Advanced Assistive Devices
Premium elderly care products including power wheelchairs, advanced CPAP systems, smart monitoring devices, and robotic mobility aids carry price points that place them beyond the reach of a substantial share of the elderly population, particularly in middle- and lower-income markets. In the United States, a mid-range power wheelchair typically retails between USD 3,000 and USD 7,000, and Medicare Part B coverage is subject to documentation and prior-authorization requirements that a meaningful share of beneficiaries find difficult to fulfil.[4] Manufacturers are responding through tiered product lines and rental models, though the addressable market for premium categories remains structurally constrained by reimbursement policy and household income distribution within elderly populations.
Technological Adoption Barriers
A meaningful portion of the elderly population, particularly those in the 75-and-over cohort faces significant barriers to adopting connected and smart care products. Low digital literacy, concerns about data privacy, and the complexity of device setup and ongoing maintenance reduce effective demand relative to the technically available market. The adoption gap is widest in markets where the population aged 75 and over is growing fastest, notably Central and Eastern Europe and parts of Latin America. Manufacturers and distributors are addressing this through simplified user interfaces, caregiver-assisted onboarding programs, and partnerships with home care agencies that bundle device support as part of their service offering.
Restraints Impact Analysis
Driver
(~) % Impact on CAGR Forecast
Geographic Relevance
Impact Timeline
High cost of advanced assistive devices
-0.8%
Global - most acute in LATAM, MEA
Medium term (2–4 years)
Technological adoption barriers
-0.6%
Global - concentrated in the 75+ cohort
Short term (≤ 2 years)
Elderly Care Products Market Trends
Shift Toward Home-Based Care and Aging-in-Place
The structural preference for aging-in-place is reshaping product demand across virtually every category in the market. Home-compatible formats lighter-weight mobility aids, portable medical monitoring devices, and user-operable bathroom safety equipment are gaining share at the expense of institutional-grade equivalents that require professional handling or facility installation. The underlying driver is a convergence of consumer preference, health system economics, and policy direction: home-based care consistently demonstrates lower per-episode cost than inpatient or nursing facility alternatives, and payers in North America and Europe are actively redirecting reimbursement toward community and home settings.
The practical scale of this shift is significant. The US Centres for Medicare & Medicaid Services expanded its Acute Hospital Care at Home program in 2023, certifying over 280 hospital systems across 37 states to deliver acute-level care in home environments with measurable downstream effects on orders for telehealth-compatible monitoring devices, portable infusion systems, and home-adapted safety equipment among participating health systems. In our Q1 2026 survey of 200 home care product procurement leads across the United States and Western Europe, 68% reported increasing their home-compatible product budget by more than 10% compared to 2024, with mobility aids and remote monitoring devices among the top three categories of expanded spend. The implication for product manufacturers is direct: home-compatible specifications are ceasing to be a niche product variant and are becoming the default design standard for new product development across the elderly care products market.
Rising Adoption of Smart and Connected Devices
Smart and connected elderly care devices are transitioning from aspirational product categories to standard procurement items among institutional operators and home care agencies. Fall-detection wearables, connected medication dispensers, voice-activated emergency response systems, and continuous glucose monitors are among the device categories recording the fastest adoption rates in the 65-to-74 age cohort, which is more digitally proficient than earlier generations of elderly users. Koninklijke Philips NV's Lifeline Medical Alert service a GPS-enabled emergency response platform for home users had over 7 million subscribers globally as of 2024, illustrating the scale achievable in connected monitoring when device simplicity and reliable response infrastructure are combined.
OMRON Corporation's Evolv wireless blood pressure monitor, which integrates with a companion smartphone application and flags irregular pulse readings for clinical review, has been adopted by major pharmacy chains in North America and Japan as a standard over-the-counter connectivity device a transition that reflects the broader mainstreaming of smart health monitoring among retail consumers. At the institutional level, Essity's TENA SmartCare Change Indicator launched in the United Kingdom in May 2024 demonstrates how even traditional consumable categories such as incontinence care are being digitally integrated: the connected sensor alerts caregivers to incontinence episodes via a smartphone application, reducing unnecessary check frequency and improving care workflow efficiency. The second-order effect of this adoption trajectory is an increase in data-asset value for manufacturers: device-generated usage data is becoming a basis for subscription pricing, outcomes-based contracting, and platform expansion into adjacent care management services.
Integration of Digital Health and Telehealth Ecosystems
The convergence of elderly care products with telehealth platforms and electronic health record (EHR) systems is creating real-time data loops that improve care coordination and reduce reactive hospitalization. Remote patient monitoring platforms including those operated by Best Buy Health through the Lively service, ResMed through its myAir connected care platform, and Medtronic through its cardiac monitoring division are increasingly interoperating with hospital-based EHR systems, enabling care teams to adjust treatment protocols based on continuous device-generated data rather than episodic clinical visits.[5] Peer-reviewed research published in The Lancet Digital Health in 2023 found that remote monitoring programs for elderly patients with heart failure reduced 30-day readmission rates by 18–22% relative to standard discharge protocols a finding that has materially accelerated institutional procurement of interoperable monitoring devices.[6]
The practical implication for product manufacturers is that device interoperability the capability to connect seamlessly with major telehealth and EHR ecosystems is becoming a formal procurement prerequisite, particularly for institutional buyers operating at scale. ResMed's August 2024 expansion of its myAir platform to integrate with Apple Health and Google Health Connect is an illustrative example of this dynamic: by embedding into widely used health data aggregation environments, device manufacturers are converting their hardware install base into a persistent care data infrastructure with network-effect economics. Across the market, this trend is sharpening the competitive distinction between manufacturers with platform-grade connectivity capabilities and those competing on hardware specifications alone.
Elderly Care Products Market Analysis
By Product Type
Medical Devices
Medical devices represent the single largest segment of the elderly care products market, holding a 20.4% share in 2025 and projected to grow at a CAGR of 6% through 2035 the fastest rate among all product type categories. The segment encompasses blood pressure monitors, cardiac rhythm monitors, continuous glucose meters, CPAP and BiPAP respiratory devices, and hearing aids, with demand structurally linked to the prevalence of cardiovascular disease, diabetes, and respiratory conditions in the elderly population. Specific platforms driving segment growth include Koninklijke Philips NV's DreamStation 2 CPAP system, which incorporates cellular connectivity for remote compliance monitoring by sleep therapists and physicians, and OMRON Corporation's HeartGuide wearable blood pressure monitor the first wrist-worn device to receive FDA clearance for oscillometric blood pressure measurement and a product that has materially advanced patient self-monitoring protocols in ambulatory elder care settings. Institutional procurement of medical devices for nursing facilities and CCRCs is concentrated in bulk-supply contracts with distributors such as Medline Industries LP, which provides category management and formulary optimization services alongside product supply.
Nutritional Supplements
Nutritional supplements hold an 18.9% share and are growing at a 5.6% CAGR, driven by escalating clinical recognition of malnutrition and sarcopenia as modifiable contributors to elderly hospital readmission rates. Abbott's Ensure product line comprising Ensure Original, Ensure Plus, and the clinical Ensure Compact variant, alongside the October 2024 launch of Ensure Complete targeting elderly patients at risk of sarcopenia remains the most widely distributed oral nutritional supplement range in North America and Western Europe, with coverage across retail pharmacy, grocery, and clinical procurement channels. In our Q4 2025 research interviews with 35 clinical dietitians across US hospital systems, 74% reported that oral nutritional supplementation protocols for elderly patients had been expanded or formalized since 2022, citing evidence-based guidance from the American Society for Parenteral and Enteral Nutrition as the primary driver of protocol change.
Mobility Products and Incontinence Products
Mobility products and incontinence products together account for approximately 30% of market value, anchoring the elderly care products market's volume base across all care settings and geographies.
By End Use
Home-Based Care
Home-based care is the dominant end-use segment, representing 39.6% of 2025 market revenue and growing at a 5.9% CAGR the highest rate among all end-use categories. The segment encompasses a diverse product mix: consumable incontinence products and nutritional supplements ordered through subscription models, durable mobility aids and bathroom safety equipment purchased through retail and e-commerce channels, and connected medical devices procured through home health agency programs. Drive DeVilbiss Healthcare's range of home-compatible rollators and transport wheelchairs exemplifies the product profile best aligned with home-based care procurement, combining clinical functionality with user-operable portability. Kimberly-Clark's Depend incontinence product range, distributed through US retail pharmacy and grocery channels and increasingly available through subscription e-commerce via Amazon Subscribe & Save, similarly reflects the consolidation of consumable elderly care spend in the home setting. The structural resilience of the home-based care segment is reinforced by payer-level incentives: Medicare Advantage plans and managed Medicaid programs have systematically expanded reimbursement for home-based monitoring and assistive equipment over the 2021–2024 period, reducing the out-of-pocket burden that historically constrained take-up rates in lower-income elderly households.
Hospitals & Clinics
Hospitals and clinics retain a 20.5% share and grow at a 4.6% CAGR, reflecting their role as the primary acute-care interface for elderly patients, where clinical-grade medical devices and high-protein nutritional supplementation form the core of product demand.
Assisted Living & Continuing Care Retirement
Assisted living and CCRCs represent 15.1% of 2025 revenue and are growing at 5.7% CAGR, supported by post-pandemic occupancy recovery and the ongoing expansion of purpose-built retirement community infrastructure across North America. At the product level, this segment skews toward comfort care, mobility equipment, and medical monitoring categories where product longevity, clinical compliance, and ease of caregiver operation carry equal weight alongside price in procurement decisions. The long-term growth outlook for institutional segments is underpinned by demographic fundamentals: as the baby-boom cohort transitions through its late seventies and eighties over the 2025–2035 forecast period, demand for both home-based and institutional elderly care products is positioned to compound across all major geographies.
By Distribution Channel
Offline channels account for 57.3% of global Elderly Care Products sales in 2025, reflecting the category's status as a high-consideration purchase where consumers typically seek in-store demonstrations, installation consultation, and tactile product assessment before committing to a purchase decision. Large-format home improvement retailers including The Home Depot and Lowe's in North America, and MediaMarkt and Currys in Europe remain the dominant point-of-sale for smart dishwashers, particularly in the built-in segment where installation coordination with kitchen contractors is a standard purchase component. The offline channel's projected CAGR of 8.1% through 2035 reflects steady growth rather than structural decline, as OEM-exclusive showrooms and appliance specialist retailers continue to invest in interactive smart home display environments that allow consumers to experience connected appliance ecosystems prior to purchase.
The online channel, at 42.7% share in 2025, is growing at a faster CAGR of 9.3% through 2035, driven by direct-to-consumer brand platforms, appliance-specialist e-commerce, and integrated marketplace ecosystems particularly JD.com and Tmall in China, Amazon in North America, and Flipkart and Amazon India in South Asia. The more consequential growth driver within the online segment is the proliferation of OEM-owned digital storefronts: BSH Hausgeräte, Samsung, and LG have each invested in direct commerce infrastructure that combines e-commerce transaction capability with smart home ecosystem upsell pathways, reducing reliance on third-party retailer margin and enabling richer post-sale engagement. A closer read of channel mix data reveals that countertop and freestanding dishwasher formats which require no professional installation and carry lower price points are disproportionately purchased online, while built-in and semi-integrated models retain a higher offline share due to the installation complexity involved.
By Region
North America Elderly Care Products Market
North America accounts for 32.8% of global elderly care products market revenue in 2025 and is projected to grow at a 4.8% CAGR through 2035, with the United States representing the dominant national market. Federal data from the Centres for Medicare & Medicaid Services confirms that durable medical equipment expenditures for elderly Medicare beneficiaries reached USD 13.2 billion in 2023, with mobility devices, CPAP equipment, and blood glucose monitors among the highest-volume reimbursed categories. The US market is further reinforced by the expansion of the Acute Hospital Care at Home program which certified over 280 hospital systems across 37 states in 2023 to deliver acute-level care in home environments generating measurable downstream demand for telehealth-compatible monitoring devices and home-adapted safety equipment. Canada contributes incrementally to the North America market through provincial coverage programs, including Ontario's Assistive Devices Program, which covers more than 8,000 product types across mobility, hearing, and respiratory categories a model increasingly referenced in other provinces as they expand home care reimbursement frameworks.
Europe Elderly Care Products Market
Europe represents 25.3% of global market revenue in 2025, with a CAGR of 5% through 2035. Germany leads regional revenue, supported by the statutory long-term care insurance system (Pflegeversicherung), which covers a defined range of assistive devices and home care products for elderly beneficiaries creating a reliable, policy-backstopped demand base for manufacturers operating in this space. Eurostat data indicates that 21.1% of the EU population was aged 65 or over in 2023, a figure projected to reach 29% by 2050, establishing the structural demographic foundation for long-term regional demand.[7] The United Kingdom ranks among the top three emerging countries globally in the market, where National Health Service-funded home care services are expanding under the Better Care Fund framework, directing integrated health and social care spending toward community-based elderly support. France's Plan Grand Age program and Spain's growing dependency benefit system represent additional policy levers broadening the publicly funded market for home and institutional elderly care products, with each program creating incremental procurement demand for mobility aids, incontinence care, and connected monitoring devices.
Asia Pacific Elderly Care Products Market
Asia Pacific is the fastest-growing region in the market, expanding at a CAGR of 7% through 2035 from a 23.5% revenue base in 2025. China had an estimated 216 million people aged 65 and over in 2023 and is implementing the 14th Five-Year Plan (2021–2025) for elderly care services, which includes national investment targets for community-based care infrastructure and domestic elderly care product manufacturing capacity creating a dual dynamic of rising demand and accelerating local supply development.[8] India is among the top three emerging markets globally in the elderly care products market, where the elderly population is expected to nearly double to approximately 300 million by 2050, and where the National Programme for Health Care of the Elderly (NPHCE) is expanding institutional demand for medical devices and nutritional products. Japan and South Korea both established markets with advanced elderly care systems serve as technology reference markets for the broader region, with AI-assisted monitoring platforms and robotic mobility aids commercialized in these markets typically preceding broader Asia Pacific rollouts by two to four years; OMRON's November 2023 launch of the Evolv wireless blood pressure monitor in India through Apollo Pharmacy represents a characteristic pattern of technology transfer from established to emerging Asia Pacific markets.
Elderly Care Products Market Share
The market exhibits moderate concentration at the global level. The top five players Medline Industries LP, Abbott, Essity, Koninklijke Philips NV, and Sonova collectively hold approximately 40% of global market revenue as of 2025. The remaining 60% is distributed across a broad base of regional and single-category operators, reflecting the market's structural diversity across product types, geographies, and care settings.
Medline Industries LP leads with a 12% share, underpinned by its position as the largest privately held manufacturer and distributor of medical supplies in the United States. The company's competitive advantage derives from portfolio breadth spanning incontinence products, wound care, surgical supplies, and mobility aids and from deep integration with hospital, long-term care, and home health procurement networks that give it category management influence beyond its direct product share. In January 2025, Medline completed the acquisition of a majority stake in a US-based home health software provider, accelerating its integrated care delivery strategy and extending its competitive footprint into the software-enabled care coordination layer of the home-based elderly care market. Abbott holds an 8% share, concentrated primarily in nutritional supplements through the Ensure and Glucerna product lines, as well as in cardiac monitoring through its cardiac rhythm management portfolio.
Essity commands a 7% share, derived principally from its TENA incontinence care brand the leading incontinence product line in Europe and a strong performer in North America and Latin America. The May 2024 launch of TENA SmartCare Change Indicator in the United Kingdom represents Essity's expansion into connected care, embedding digital monitoring capability into a historically analog consumable category. Koninklijke Philips NV and Sonova each account for 6.5% of global elderly care products market revenue. Philips competes across personal emergency response, respiratory care, and connected monitoring, with its integration of hardware and digital health software serving as the primary competitive differentiator illustrated by its April 2025 expansion of Lifeline Medical Alert services to include AI-powered fall detection as a standard home subscriber feature. Sonova dominates the hearing care segment through its Phonak and Unitron hearing aid brands, a category of significant scale within this space given that age-related hearing loss affects an estimated one in three people aged 65 and over.
Competitive differentiation operates across three principal axes: product portfolio breadth and clinical credibility, distribution network depth and institutional procurement relationships, and digital connectivity capability. Companies with the strongest positions across all three axes Medline, Abbott, and Philips are best positioned to capture disproportionate share as home-based care and connected device adoption accelerate. M&A activity has been notable beyond Medline's 2025 acquisition: ResMed Inc acquired the Brightree home health software business and has since expanded its connected care ecosystem around the myAir platform, while Baxter International restructured its hospital products business since 2023 to increase strategic focus on outpatient and home care settings. In our Q3 2025 expert panel drawing on conversations with six competitive strategy leads across major elderly care product companies’ portfolio consolidation around home-compatible formats and digital integration with telehealth platforms were cited as the two most frequently prioritized strategic objectives for the 2025–2027 period. The data indicates that the competitive landscape of the market is approaching a structural inflection: scale advantages in distribution and procurement are being augmented by data-network effects from connected device ecosystems, raising barriers to entry for operators without both capabilities simultaneously.
Elderly Care Products Market Companies
Major players operating in the elderly care products industry are:
Abbott, Baxter International, Bruno Independent Living Aids, Drive DeVilbiss Healthcare, Essity, Golden Technologies, Kimberly-Clark Corporation, Koninklijke Philips NV, Medline Industries LP, Medtronic, OMRON Corp, Pride Mobility, ResMed Inc, Sonova, Sunrise Medical.
These fifteen companies collectively span the full product breadth of the elderly care products market from durable mobility equipment and precision medical devices to disposable incontinence care and clinical nutritional formulations and operate across the complete spectrum of care settings, from acute hospital environments to home-based and community-supported care.
Abbott is a global health technology company whose elderly care portfolio is anchored by the Ensure and Glucerna nutritional supplement lines and by the FreeStyle Libre continuous glucose monitoring system. The October 2024 launch of Ensure Complete a reformulated high-protein, low-sugar supplement targeting elderly patients at risk of sarcopenia reflects Abbott's active investment in clinical differentiation within the nutritional supplements segment. Distribution reach across retail pharmacy, hospital formulary, and direct-to-consumer channels positions Abbott as the leading single-category operator in nutritional supplements and a significant participant in home-based chronic disease management.
Baxter International operates in the market through its renal care and nutrition infusion businesses, supplying hospitals and home infusion providers with parenteral nutrition products and peritoneal dialysis systems. The company's restructuring since 2023 has placed increased strategic emphasis on outpatient and home care settings a direction well aligned with the structural trend in elderly care delivery away from acute facility environments.
Bruno Independent Living Aids specializes in stair lifts and vehicle accessibility equipment, with products such as the Bruno Elan and Elite stairlift series serving the home modification and aging-in-place segment. The company distributes exclusively through a certified dealer network across North America, providing installation and service alongside product supply a model that embeds Bruno into the home care supply chain at the point of professional assessment and recommendation.
Drive DeVilbiss Healthcare is one of the largest manufacturers and distributors of durable medical equipment globally, with a product range encompassing wheelchairs, rollators, oxygen concentrators, and bathroom safety aids. In February 2024, the company received FDA clearance for a new portable oxygen concentrator model targeting home-based elderly COPD patients, featuring an extended battery life of up to eight hours for active-lifestyle users an illustrative example of the product innovation priorities aligned with home-compatible care delivery.
Essity is a Swedish hygiene and health company whose TENA brand leads the global incontinence care segment within the elderly care products market. The TENA product range covers discreet personal care items, clinical institutional pads, and complementary skin care formulations, with the TENA SmartCare connected sensor system representing the brand's expansion into the digital health interface of incontinence management.
Golden Technologies manufactures lift chairs and mobility scooters for elderly users, with the Golden Lift Chair series among the most widely specified products in the US home comfort care segment. The company distributes through home medical equipment dealers and retail health channels nationally, maintaining strong presence in the aging-in-place product category.
Kimberly-Clark Corporation competes in the incontinence and personal care segment through its Depend and Poise brands, which hold leading positions in North America's retail incontinence market. The expansion of Depend into subscription-based home delivery models via platforms such as Amazon Subscribe & Save reflects Kimberly-Clark's alignment with the structural shift toward home-based elderly care procurement and recurring-revenue channel economics.
Koninklijke Philips NV is active across multiple elderly care product categories: personal emergency response systems under the Lifeline brand with over 7 million global subscribers as of 2024, CPAP and BiPAP respiratory devices under the DreamStation 2 platform, and connected health monitoring services. Philips' integration of hardware, software, and service delivery distinguishes its competitive positioning within the elderly care products market and positions it favourably as care delivery moves toward platform-based management models.
Medline Industries LP is the global market leader and the largest privately held medical supply manufacturer in the United States. Its elderly care portfolio spans incontinence care, wound management, mobility aids, and personal hygiene products, with distribution spanning hospital systems, long-term care facilities, home health agencies, and e-commerce channels. The January 2025 acquisition of a majority stake in a US home health software provider extends Medline's competitive position beyond physical supply into care coordination infrastructure a breadth of coverage that no single competitor has replicated.
Medtronic participates in the elderly care products market through its cardiac monitoring, insulin delivery, and pelvic health divisions. The company's remote cardiac monitoring devices are widely deployed in elderly heart disease management programs, and its Interstim neuromodulation system addresses pelvic health conditions with high prevalence in the elderly population, including overactive bladder and urinary retention.
OMRON Corp is a leading manufacturer of blood pressure monitors and respiratory care devices, with strong retail and clinical distribution across Japan, North America, and Europe. The Evolv wireless blood pressure monitor and the NE-C803 nebulizer are among the company's most widely distributed elderly care products, and OMRON's November 2023 launch of the Evolv in India through Apollo Pharmacy marks a significant emerging-market expansion within the Asia Pacific elderly care products market.
Pride Mobility is one of the largest manufacturers of power wheelchairs and mobility scooters in the United States, with the Jazzy power chair series and Go-Go travel scooter line covering both institutional and personal use segments. Products are reimbursable under Medicare Part B, which provides a significant structural channel advantage in the US market particularly given the USD 3,000–7,000 retail price range for mid-tier power wheelchairs.
ResMed Inc leads the global sleep therapy and respiratory care segment, with CPAP, BiPAP, and adaptive servo-ventilation devices distributed through DME providers, pharmacies, and directly to patients. The August 2024 expansion of ResMed's myAir connected care platform to integrate with Apple Health and Google Health Connect enables seamless CPAP compliance data sharing between elderly patients and care teams advancing the platform's value proposition within the broader telehealth-integrated elderly care ecosystem.
Sonova is the global leader in hearing care, operating the Phonak, Unitron, and AudioNova brands across hearing aids, cochlear implants, and hearing care retail services. The Phonak Lumity platform commercially available across 26 markets as of July 2023, featuring AutoSense OS 5.0 for automatic environmental acoustic adjustment and direct Bluetooth streaming to both iPhone and Android devices represents the current state of the art in consumer hearing aid technology within the elderly care products market.
Sunrise Medical manufactures manual and power wheelchairs under the Quickie and Breezy brand names, serving institutional procurement, rehabilitation specialists, and personal use segments across North America and Europe. The Quickie Q700 M power wheelchair is among the most specified models in complex rehabilitation and long-term care institutional procurement, with clinical customization capabilities that position it favourably in the premium assistive device tier.
12% market share
The collective market share in 2025 is 40%
Elderly Care Products Industry News
Market Concentration Score
The elderly care products market scores 5 out of 10 on the concentration scale a moderate rating consistent with the top five players (Medline Industries LP, Abbott, Essity, Koninklijke Philips NV, and Sonova) collectively holding approximately 40% of global revenue in 2025, while the remaining 60% is distributed across a broad base of regional specialists and single-category operators, indicating meaningful competitive fragmentation beneath the leading tier.
The elderly care products market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue (USD Billion) & volume (Thousand Units) from 2022 to 2035, for the following segments:
Click here to Buy Section of this Report
Market, by Product Type
Market, by Care Type
Market, by End Use
Market, by Distribution Channel
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →